Covaxin | WHO
Covid19: WHO suspends UN supply for Bharat Biotech's Covaxin
Geneva: The World Health Organisation (WHO) has suspended the supply of Covaxin made by Indian manufacturer Bharat Biotech to upgrade facilities and address deficiencies revealed in an inspection, media reports said.
Reuters reported that WHO has asked the countries that have received the vaccine to take appropriate steps according to the findings but did not specify what the required measures are.
However, the health body mentioned that the vaccine is effective and that there are no safety concerns linked to it.
It said that the suspension comes after the WHO post-emergency use listing (EUL) inspection conducted from March 14 to 22.
WHO said that Bharat Biotech has confirmed its commitment to the suspension of vaccine production for export.
The WHO said that the company has "committed to comply by addressing the GMP deficiencies and is developing a corrective and preventive action plan, for submission to the Drugs Controller General of India (DCGI)and WHO".
On Friday, Bharat Biotech said it was slowing vaccine production due to reduced demand along with a fall in infections and a wider vaccination drive run by the government.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
